All In Biotech

Drug Trial Radar · NCT07512596

Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

Randomized, Double-blind, Parallel-controlled, Multicenter Phase II Clinical Study to Evaluate the Efficacy and Safety of Polymyxin E2 Mesylate Intravenous Infusion Combined With Nebulized Inhalation in the Treatment of Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia Caused by Carbapenem-resistant Gram-negative Bacteria

Last checked: Nov 19, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

Jul 21, 2026

Primary completion

Jul 2027

Study completion Jul 2027

Sponsor

Sponsor type
Industry
First posted
Apr 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria.

Conditions

  • Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia

Interventions

  • TQD3524Drug

    After entering the body, TQD3524 can be hydrolyzed into polymyxin E2 and its derivatives, exerting bactericidal effects .

  • Meropenem for injectionDrug

    Meropenem for injection is a β-lactam.

  • Colistimethate Sodium for InjectionDrug

    Colistimethate Sodium for Injection is a prodrug of polymyxin E. After entering the body, polymyxin E mesylate is hydrolyzed to polymyxin E (colistin), which exerts bactericidal activity.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportion of subjects who achieved clinical cureTime frame: Up to 28 days
  2. The percentage difference in subjects achieving clinical cure between the experimental group and the control groupTime frame: Up to 28 days

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, Anhui, China · Not yet recruiting

  • Beijing Tsinghua Changgung Hospital

    Beijing, Beijing Municipality, China · Not yet recruiting

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China · Not yet recruiting

  • Foshan Nanhai District People's Hospital

    Foshan, Guangdong, China · Not yet recruiting

  • The First Clinical College of Guangzhou Medical University

    Guangzhou, Guangdong, China · Not yet recruiting

  • Peking University Shenzhen Hospital

    Shenzhen, Guangdong, China · Not yet recruiting

  • The Fifth Affiliated Hospital, Sun Yat-sen University

    Zhuhai, Guangdong, China · Not yet recruiting

  • The Second Hospital Of Hebei Medical University

    Shijiazhuang, Hebei, China · Not yet recruiting

  • Henan Provincial People's Hospital

    Zhengzhou, Henan, China · Not yet recruiting

  • Zhengzhou Central Hospital

    Zhengzhou, Henan, China · Not yet recruiting

  • The Fifth Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China · Not yet recruiting

  • The Second Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China · Not yet recruiting

  • Xiangya Hospital of Central South University

    Changsha, Hunan, China · Not yet recruiting

  • People's Hospital of Hunan Province

    Changsha, Hunan, China · Not yet recruiting

  • The Third Hospital of Changsha

    Changsha, Hunan, China · Not yet recruiting

  • Northern Jiangsu People's Hospital

    Yangzhou, Jiangsu, China · Not yet recruiting

  • First Affiliated Hospital of Gannan Medical University

    Ganzhou, Jiangxi, China · Not yet recruiting

  • The First Affiliated Hospital of Xi'an Jiao Tong University

    Xi'an, Shaanxi, China · Not yet recruiting

  • Xi'an Chest Hospital

    Xi'an, Shaanxi, China · Not yet recruiting

  • Yan'an University Xianyang Hospital

    Xianyang, Shaanxi, China · Not yet recruiting

  • Shanghai General Hospital

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • Shanghai Pulmonary Hospital

    Shanghai, Shanghai Municipality, China · Not yet recruiting

  • Chengdu Third People's Hospital

    Chengdu, Sichuan, China · Not yet recruiting

  • Nuclear Industry 416 Hospital

    Chengdu, Sichuan, China · Not yet recruiting

  • Sichuan Provincial People's Hospital

    Chengdu, Sichuan, China · Recruiting

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, China · Not yet recruiting

  • Tianjin First Central Hospital

    Tianjin, Tianjin Municipality, China · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.